IMMOLENS: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
IMMOLENS
Largest movements
- Deferred charges and accrued income -€9,293
no longer reported in 2024 (was €9,293)
- Cash -€2,162
down €2,162 (-75.3%), from €2,870 to €707
mainly Trade debts (-€9,566) and Other debts (-€3,000)
- Trade debts -€9,566
down €9,566 (-95.0%), from €10,069 to €503
- Other debts -€3,000
down €3,000 (-10.9%), from €27,617 to €24,617
- Profit (loss) carried forward +€1,110
up €1,110 (+1.0%), from -€112,285 to -€111,175
- Gross operating margin +€1,011
up €1,011 (+14.0%), from €7,200 to €8,211
- Other operating charges +€213
up €213 (+3.1%), from €6,829 to €7,041
From the 2023 result to the 2024 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2023 and 2024 balance sheets and the 2024 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2023 | 2024 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €12,163 | €707 | -€11,456 | -94.2% |
| Current assets | 29/58 | €12,163 | €707 | -€11,456 | -94.2% |
| Cash at bank and in hand | 54/58 | €2,870 | €707 | -€2,162 | -75.3% |
| Deferred charges and accrued income | 490/1 | €9,293 | - | -€9,293 | |
| Total equity and liabilities | 10/49 | €12,163 | €707 | -€11,456 | -94.2% |
| Equity | 10/15 | -€25,523 | -€24,412 | +€1,110 | +4.4% |
| Contributions | 10/11 | €86,763 | €86,763 | = | 0.0% |
| Capital | 10 | €86,763 | €86,763 | = | 0.0% |
| Issued capital | 100 | €86,763 | €86,763 | = | 0.0% |
| Profit (loss) carried forward | 14 | -€112,285 | -€111,175 | +€1,110 | +1.0% |
| Amounts payable | 17/49 | €37,686 | €25,120 | -€12,566 | -33.3% |
| Amounts payable within one year | 42/48 | €37,686 | €25,120 | -€12,566 | -33.3% |
| Trade debts | 44 | €10,069 | €503 | -€9,566 | -95.0% |
| Suppliers | 440/4 | €10,069 | €503 | -€9,566 | -95.0% |
| Other amounts payable | 47/48 | €27,617 | €24,617 | -€3,000 | -10.9% |
| Other operating charges | 640/8 | €6,829 | €7,041 | +€213 | +3.1% |
| Gross operating margin | 9900 | €7,200 | €8,211 | +€1,011 | +14.0% |
| Operating profit (loss) | 9901 | €371 | €1,170 | +€798 | +215% |
| Financial charges | 65/66B | €61 | €60 | -€2 | -2.6% |
| Recurring financial charges | 65 | €61 | €60 | -€2 | -2.6% |
| Profit (loss) for the period before taxes | 9903 | €310 | €1,110 | +€800 | +258% |
| Profit (loss) for the period | 9904 | €310 | €1,110 | +€800 | +258% |
| Profit (loss) for the period to be appropriated | 9905 | €310 | €1,110 | +€800 | +258% |
Source: filed annual accounts (NBB), financial years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 16 October 2026 via checked.be.